In Brief: InStent
This article was originally published in The Gray Sheet
Executive Summary
InStent: Receives FDA 510(k) clearance for the EndoCoil and EndoCoil-T biliary stents for use in treating patients with pancreatic cancer. The self-expanding, metallic devices "are designed to expand the bile duct to a larger diameter, thus permitting bile passage." Bard's radiology division has exclusive U.S. distribution rights to EndoCoil-T, which will be targeted to interventional radiologists